Sobi’s strength in haematology to be showcased at ASH 2024
STOCKHOLM, Dec. 3, 2024 /PRNewswire/ — New data from Sobi® and partners will be presented at the 66th Annual Meeting of the American Society of Hematology (ASH) in San Diego, CA (USA) from the 7th – 10th of December 2024. During the meeting several analyses will be presented on haem
Skanska builds tram depot in Helsinki, Finland, for EUR 252M, about SEK 2.9 billion
STOCKHOLM, Dec. 3, 2024 /PRNewswire/ — Skanska has signed a contract with City Transport Ltd to build a tram depot in Helsinki, Finland. The contract is worth EUR 252M, about SEK 2.9 billion, which will be included in the Nordic order bookings for the fourth quarter of 2024. The new depot cons
The Heavenly Voice That Inspires: Ani Bond: Choying Drolma Captivates Hong Kong Audiences; Screenings Extended Until 09 December
HONG KONG, Dec. 3, 2024 /PRNewswire/ — On the evening of 30 November, Hong Kong’s Premiere Elements hosted the highly anticipated premiere of Ani Bond: Choying Drolma. This musical documentary film chronicles the extraordinary life of Nepali nun Ani Choying Drolma, blending her spiritua
IRIS Software Group Announces Intent to Acquire Dext Software Ltd.
Acquisition to create an integrated, end-to-end solution, advance partner integrations, and drive product innovation for accountants and businesses globally LONDON, Dec. 3, 2024 /PRNewswire/ — IRIS Software Group (IRIS), a leading global provider of accountancy, education management, HR and
ASSA ABLOY acquires 9Solutions in Finland
STOCKHOLM, Dec. 3, 2024 /PRNewswire/ — ASSA ABLOY has acquired 9Solutions, a Finnish provider of highly integrated AI-powered real time locating healthcare solutions for critical communication and collaboration, with a focus on senior care. “I am very pleased to welcome 9Solutions into t
Bharath Advanced Therapeutics (BAT) advancing Cancer treatment in India by setting new benchmarks in affordable and transformational care
HYDERABAD, India, Dec. 3, 2024 /PRNewswire/ — Bharath Advanced Therapeutics (BAT), as a key organiser of Cancer NEXT 2024 alongside Nizam’s Institute of Medical Sciences (NIMS) and Federation of Asian Biotech Associations (FABA), successfully led the conference’s scientific program
Today Essity hosts its Capital Markets Day – Accelerating Profitable Growth
STOCKHOLM, Dec. 3, 2024 /PRNewswire/ — Today Essity hosts its Capital Markets Day at the company’s production facility for hygiene products in Valls, Spain. Essity will present its strategy for accelerating profitable growth and the roadmap to achieving the company’s financial targ
" title="ZEISS Debuts MYO 200 Biometer for Myopia Management in Hong Kong, Built on ZEISS “Gold Standard” Technology to Safeguard the Visual Health of Children and Adolescents
HONG KONG, Dec. 3, 2024 /PRNewswire/ — Global optical technology leader ZEISS debuted the ZEISS MYO 200 Biometer for Myopia Management in Hong Kong on November 28th, to provide more precise myopia control and improved visual health for children and adolescents. Specifically tailored for child
Genethon and Hansa Biopharma announce initiation of a Phase 2 trial of imlifidase as a pre-treatment to GNT-0003 in severe Crigler-Najjar syndrome
The trial will be conducted in patients with pre-existing anti-AAV antibodies which limit use of gene therapy treatment. LUND, Sweden and EVRY, France, Dec. 3, 2024 /PRNewswire/ — Hansa Biopharma, “Hansa” (Nasdaq Stockholm: HNSA) and Genethon, a pioneer and a leader in gene therapy
Pfizer Receives Authorization from Health Authority for Its 20-valent Pneumococcal Conjugate Vaccine for Infants and Children
In Hong Kong, the 20-valent Pneumococcal Conjugate Vaccine (PCV20) that offers the broadest serotype coverage of any pediatric pneumococcal conjugate vaccine – helping to fight against 20 serotypes leading to most of the invasive pneumococcal diseases and pneumonia[i],[ii] – is now approved for
